Imatinib pharmacokinetics and its correlation with response in chronic-phase chronic myelogenous leukemia
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2016
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 02 Oct 2016 Status changed from not yet recruiting to completed.
- 06 May 2008 New trial record.